Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10913157rdf:typepubmed:Citationlld:pubmed
pubmed-article:10913157lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10913157lifeskim:mentionsumls-concept:C0248266lld:lifeskim
pubmed-article:10913157lifeskim:mentionsumls-concept:C0007595lld:lifeskim
pubmed-article:10913157lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:10913157lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:10913157lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:10913157lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:10913157lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:10913157pubmed:issue41lld:pubmed
pubmed-article:10913157pubmed:dateCreated2000-11-13lld:pubmed
pubmed-article:10913157pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10913157pubmed:abstractTextAlthough ectopic expression of the cholecystokinin B/gastrin receptor (CCK-BR) is widely reported in human colorectal cancers, its role in mediating the proliferative effects of gastrin1-17 (G-17) on these cancers is unknown. Here we report the isolation of a novel splice variant of CCK-BR that exhibits constitutive (ligand-independent) activation of pathways regulating intracellular free Ca(2+) ([Ca(2+)](i)) and cell growth. The splice variant (designated CCK-BRi4sv for intron 4-containing splice variant) is expressed in colorectal cancers but not in normal colonic mucosa adjacent to the cancer. Balb3T3 cells expressing CCK-BRi4sv exhibited spontaneous, ligand-independent, oscillatory increases in [Ca(2+)](i), whereas cells expressing wild-type CCK-BR did not. Primary cultures of cells isolated from resected colorectal cancers also exhibited a similar pattern of spontaneous [Ca(2+)](i) oscillations. For both Balb3T3 and primary tumor cells, application of G-17 (10 and 200 nm, respectively) caused an increase in [Ca(2+)](i). Selective CCK-BR antagonists blocked the G-17-stimulated Ca(2+) responses but not the spontaneous [Ca(2+)](i) oscillations. Cells expressing CCK-BRi4sv exhibited an increased growth rate ( approximately 2.5-fold), in the absence of G-17, compared with cells expressing wild-type CCK-BR. The selective pattern of expression, constitutive activity, and trophic action associated with CCK-BRi4sv suggest that this variant may regulate colorectal cancer cell proliferation though a gastrin-independent mechanism.lld:pubmed
pubmed-article:10913157pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10913157pubmed:languageenglld:pubmed
pubmed-article:10913157pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10913157pubmed:citationSubsetIMlld:pubmed
pubmed-article:10913157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10913157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10913157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10913157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10913157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10913157pubmed:statusMEDLINElld:pubmed
pubmed-article:10913157pubmed:monthOctlld:pubmed
pubmed-article:10913157pubmed:issn0021-9258lld:pubmed
pubmed-article:10913157pubmed:authorpubmed-author:TownsendC...lld:pubmed
pubmed-article:10913157pubmed:authorpubmed-author:SunW WWWlld:pubmed
pubmed-article:10913157pubmed:authorpubmed-author:HellmichM RMRlld:pubmed
pubmed-article:10913157pubmed:authorpubmed-author:EversB MBMlld:pubmed
pubmed-article:10913157pubmed:authorpubmed-author:FlemingR YRYlld:pubmed
pubmed-article:10913157pubmed:authorpubmed-author:HellmichH LHLlld:pubmed
pubmed-article:10913157pubmed:issnTypePrintlld:pubmed
pubmed-article:10913157pubmed:day13lld:pubmed
pubmed-article:10913157pubmed:volume275lld:pubmed
pubmed-article:10913157pubmed:ownerNLMlld:pubmed
pubmed-article:10913157pubmed:authorsCompleteYlld:pubmed
pubmed-article:10913157pubmed:pagination32122-8lld:pubmed
pubmed-article:10913157pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:meshHeadingpubmed-meshheading:10913157...lld:pubmed
pubmed-article:10913157pubmed:year2000lld:pubmed
pubmed-article:10913157pubmed:articleTitleHuman colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth.lld:pubmed
pubmed-article:10913157pubmed:affiliationDepartments of Surgery, Physiology and Biophysics, and Internal Medicine, the University of Texas Medical Branch, Galveston, Texas 77555, USA. mhellmic@utmb.edulld:pubmed
pubmed-article:10913157pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10913157pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10913157pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:887entrezgene:pubmedpubmed-article:10913157lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10913157lld:pubmed